Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLPI | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
mRNA | ATXN7 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | VSIG2 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | MT-ND3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | KRTAP10-3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | SH2B3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | TMEM74B | FIMM | pan-cancer | AAC | -0.44 | 0.009 |
mRNA | PNPLA4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | SPECC1L-ADORA2A | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
mRNA | CEP85 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |